Panbela Therapeutics (PBLA) has released an update to notify the public and investors about a regulation fd disclosure.
Panbela Therapeutics, Inc. announced the completion of its offering of common stock and associated warrants. The details of the offering, which are not considered filed under the Securities Exchange Act of 1934, are not subject to the liabilities of the act and will not be included in any filings unless specifically referenced.
For further insights into PBLA stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.
